143 related articles for article (PubMed ID: 38199172)
1. Genetically engineered mouse model of pleomorphic liposarcoma: Immunophenotyping and histologic characterization.
Brown JM; Patel R; Smith-Fry K; Ward M; Oliver T; Jones KB
Neoplasia; 2024 Feb; 48():100956. PubMed ID: 38199172
[TBL] [Abstract][Full Text] [Related]
2. A Trp53fl/flPtenfl/fl mouse model of undifferentiated pleomorphic sarcoma mediated by adeno-Cre injection and in vivo bioluminescence imaging.
Buchakjian MR; Merritt NM; Moose DL; Dupuy AJ; Tanas MR; Henry MD
PLoS One; 2017; 12(8):e0183469. PubMed ID: 28841687
[TBL] [Abstract][Full Text] [Related]
3. T-cell infiltration and clonality correlate with programmed cell death protein 1 and programmed death-ligand 1 expression in patients with soft tissue sarcomas.
Pollack SM; He Q; Yearley JH; Emerson R; Vignali M; Zhang Y; Redman MW; Baker KK; Cooper S; Donahue B; Loggers ET; Cranmer LD; Spraker MB; Seo YD; Pillarisetty VG; Ricciotti RW; Hoch BL; McClanahan TK; Murphy E; Blumenschein WM; Townson SM; Benzeno S; Riddell SR; Jones RL
Cancer; 2017 Sep; 123(17):3291-3304. PubMed ID: 28463396
[TBL] [Abstract][Full Text] [Related]
4. Pleomorphic liposarcoma: Updates and current differential diagnosis.
Anderson WJ; Jo VY
Semin Diagn Pathol; 2019 Mar; 36(2):122-128. PubMed ID: 30852046
[TBL] [Abstract][Full Text] [Related]
5. Phase II study of neoadjuvant checkpoint blockade in patients with surgically resectable undifferentiated pleomorphic sarcoma and dedifferentiated liposarcoma.
Keung EZ; Lazar AJ; Torres KE; Wang WL; Cormier JN; Ashleigh Guadagnolo B; Bishop AJ; Lin H; Hunt KK; Bird J; Lewis VO; Patel SR; Wargo JA; Somaiah N; Roland CL
BMC Cancer; 2018 Sep; 18(1):913. PubMed ID: 30249211
[TBL] [Abstract][Full Text] [Related]
6. Gene expression analysis of soft tissue sarcomas: characterization and reclassification of malignant fibrous histiocytoma.
Nakayama R; Nemoto T; Takahashi H; Ohta T; Kawai A; Seki K; Yoshida T; Toyama Y; Ichikawa H; Hasegawa T
Mod Pathol; 2007 Jul; 20(7):749-59. PubMed ID: 17464315
[TBL] [Abstract][Full Text] [Related]
7. Pleomorphic liposarcoma: a clinicopathologic analysis of 19 cases.
Downes KA; Goldblum JR; Montgomery EA; Fisher C
Mod Pathol; 2001 Mar; 14(3):179-84. PubMed ID: 11266523
[TBL] [Abstract][Full Text] [Related]
8. Cytogenetic analysis of 46 pleomorphic soft tissue sarcomas and correlation with morphologic and clinical features: a report of the CHAMP Study Group. Chromosomes and MorPhology.
Mertens F; Fletcher CD; Dal Cin P; De Wever I; Mandahl N; Mitelman F; Rosai J; Rydholm A; Sciot R; Tallini G; Van den Berghe H; Vanni R; Willén H
Genes Chromosomes Cancer; 1998 May; 22(1):16-25. PubMed ID: 9591630
[TBL] [Abstract][Full Text] [Related]
9. [Pleomorphic high-grade soft tissue sarcomas: is the subclassification up to date?].
Mechtersheimer G; Renner M; Penzel R; Schirmacher P
Pathologe; 2011 Feb; 32(1):47-56. PubMed ID: 21234572
[TBL] [Abstract][Full Text] [Related]
10. Doxorubicin resistance in a novel in vitro model of human pleomorphic liposarcoma associated with alternative lengthening of telomeres.
Mitchell MA; Johnson JE; Pascarelli K; Beeharry N; Chiourea M; Gagos S; Lev D; von Mehren M; Kipling D; Broccoli D
Mol Cancer Ther; 2010 Mar; 9(3):682-92. PubMed ID: 20197395
[TBL] [Abstract][Full Text] [Related]
11. Current molecular and therapeutic advances in liposarcoma, rhabdomyosarcoma, leiomyosarcoma, synovial sarcoma, and angiosarcoma.
Tanriverdi O; Yildiz A
J Oncol Pharm Pract; 2022 Apr; 28(3):635-645. PubMed ID: 35043739
[TBL] [Abstract][Full Text] [Related]
12. Atypical Spindle Cell/Pleomorphic Lipomatous Tumor With Sarcomatous Transformation: Clinicopathologic and Molecular Analysis of 4 Cases.
Perret R; Charville GW; Alame M; Rebier F; Soubeyran I; Gross JM; Graham D; Green DC; Kerr DA; Khan WA; Cloutier JM
Mod Pathol; 2024 Apr; 37(4):100454. PubMed ID: 38417627
[TBL] [Abstract][Full Text] [Related]
13. Immunophenotypic characterization of high grade pleomorphic sarcomas: a demographic and immunohistochemical study in a major referral center of Pakistan.
Shah H; Pervez S
J Pak Med Assoc; 2005 Mar; 55(3):101-4. PubMed ID: 15852744
[TBL] [Abstract][Full Text] [Related]
14. Subclassification of pleomorphic sarcomas: How and why should we care?
Hornick JL
Ann Diagn Pathol; 2018 Dec; 37():118-124. PubMed ID: 30340082
[TBL] [Abstract][Full Text] [Related]
15. Pleomorphic liposarcoma: a cytologic study of five cases.
Dodd LG; Sara Jiang X; Rao K; Bui MM
Diagn Cytopathol; 2015 Feb; 43(2):138-43. PubMed ID: 24652822
[TBL] [Abstract][Full Text] [Related]
16. Liposarcomas with mixed well-differentiated and pleomorphic features: a clinicopathologic study of 12 cases.
Boland JM; Weiss SW; Oliveira AM; Erickson-Johnson ML; Folpe AL
Am J Surg Pathol; 2010 Jun; 34(6):837-43. PubMed ID: 20431480
[TBL] [Abstract][Full Text] [Related]
17. Pleomorphic liposarcoma: a clinicopathological, immunohistochemical and molecular cytogenetic study of 32 additional cases.
Wang L; Ren W; Zhou X; Sheng W; Wang J
Pathol Int; 2013 Nov; 63(11):523-31. PubMed ID: 24274714
[TBL] [Abstract][Full Text] [Related]
18. Pleomorphic liposarcoma.
Oliveira AM; Nascimento AG
Semin Diagn Pathol; 2001 Nov; 18(4):274-85. PubMed ID: 11757868
[TBL] [Abstract][Full Text] [Related]
19. Myxoid pleomorphic liposarcoma-a clinicopathologic, immunohistochemical, molecular genetic and epigenetic study of 12 cases, suggesting a possible relationship with conventional pleomorphic liposarcoma.
Creytens D; Folpe AL; Koelsche C; Mentzel T; Ferdinande L; van Gorp JM; Van der Linden M; Raman L; Menten B; Fritchie K; von Deimling A; Van Dorpe J; Flucke U
Mod Pathol; 2021 Nov; 34(11):2043-2049. PubMed ID: 34168281
[TBL] [Abstract][Full Text] [Related]
20. Pleomorphic liposarcoma: clinicopathologic analysis of 57 cases.
Hornick JL; Bosenberg MW; Mentzel T; McMenamin ME; Oliveira AM; Fletcher CD
Am J Surg Pathol; 2004 Oct; 28(10):1257-67. PubMed ID: 15371941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]